Ipca Laboratories (NSE:IPCALAB) E10: ₹33.68 (As of Mar. 2026)


NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
86 GF Score
Price ₹1,618.30
GF Value ₹1,594.77
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ipca Laboratories E10?

Ipca Laboratories NSE:IPCALAB -0.18% 86 E10 is ₹33.68 as of Mar. 2026. GuruFocus rates NSE:IPCALAB with a GF Score™ of 86/100 and a GF Value™ of ₹1,594.77 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ipca Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹11.790. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹33.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ipca Laboratories's average E10 Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Ipca Laboratories's current stock price is ₹1618.30. Ipca Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹33.68. Ipca Laboratories's Shiller PE Ratio of today is 48.05.

During the past 13 years, the highest Shiller PE Ratio of Ipca Laboratories was 54.80. The lowest was 39.28. And the median was 45.54.


Ipca Laboratories  (NSE:IPCALAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ipca Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1618.30/33.68
=48.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ipca Laboratories was 54.80. The lowest was 39.28. And the median was 45.54.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ipca Laboratories E10 Related Terms


Ipca Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Ipca Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipca Laboratories E10 Chart

Ipca Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 30.75 33.68

Ipca Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.75 31.39 32.22 32.97 33.68

NSE:IPCALAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Shiller PE Ratio falls into.


NSE:IPCALAB
86GF Score
Ipca Laboratories Ltd NSE:IPCALAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ipca Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ipca Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.79/164.2724*164.2724
=11.790

Current CPI (Mar. 2026) = 164.2724.

Ipca Laboratories Quarterly Data

per share eps CPI Adj_EPS
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 2.715 111.317 4.007
201809 4.691 115.142 6.693
201812 6.299 115.142 8.987
201903 3.900 118.202 5.420
201906 5.120 120.880 6.958
201909 7.640 123.175 10.189
201912 7.815 126.235 10.170
202003 3.386 124.705 4.460
202006 17.620 127.000 22.791
202009 10.555 130.118 13.326
202012 5.230 130.889 6.564
202103 6.359 131.771 7.927
202106 12.090 134.084 14.812
202109 9.860 135.847 11.923
202112 7.760 138.161 9.227
202203 5.140 138.822 6.082
202206 5.640 142.347 6.509
202209 5.670 144.661 6.439
202212 4.250 145.763 4.790
202303 3.020 146.865 3.378
202306 6.420 150.280 7.018
202309 5.720 151.492 6.203
202312 7.090 152.924 7.616
202403 2.340 153.035 2.512
202406 7.580 155.789 7.993
202409 9.050 157.882 9.416
202412 9.780 158.323 10.148
202503 2.670 157.552 2.784
202506 9.190 159.755 9.450
202509 11.140 162.289 11.276
202512 12.860 163.281 12.938
202603 11.790 164.272 11.790

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹33.68 mean?
Ipca Laboratories (NSE:IPCALAB) has a E10 of ₹33.68 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ipca Laboratories and its competitors.
Is Ipca Laboratories' E10 too high?
Ipca Laboratories' current E10 is ₹33.68. Overall, Ipca Laboratories has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ipca Laboratories' E10 compare to ZTS?
Ipca Laboratories' E10 of ₹33.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ipca Laboratories and its competitors. Ipca Laboratories's current E10 is ₹33.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipca Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ipca Laboratories (NSE:IPCALAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,594.77, compared to a current price of ₹1,618.30 — trading 1.5% above its estimated fair value. The current E10 is ₹33.68. Ipca Laboratories' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ipca Laboratories (NSE:IPCALAB), the current E10 is ₹33.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,618.30 is trading 1.5% above its estimated GF Value™ of ₹1,594.77. GuruFocus considers Ipca Laboratories to be Fairly Valued.

Key valuation signals for NSE:IPCALAB:

  • E10: ₹33.68
  • GF Value™: ₹1,594.77 vs. price of ₹1,618.30 (1.5% above fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
86GF Score

Get the complete analysis for NSE:IPCALAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,618.30
Price
₹1,594.77
GF Value